183 related articles for article (PubMed ID: 1615481)
1. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
Tripodi A; Arbini A; Chantarangkul V; Mannucci PM
Thromb Haemost; 1992 Jan; 67(1):42-5. PubMed ID: 1615481
[TBL] [Abstract][Full Text] [Related]
2. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
3. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
4. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
5. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
Valdes-Camin R; Callahan JB; Ebert RF
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
[TBL] [Abstract][Full Text] [Related]
6. [Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study].
Barthels M; Bruhn HD; Duckert F; Meyer JG; Dati F; Fuhge P
J Clin Chem Clin Biochem; 1987 Apr; 25(4):267-80. PubMed ID: 3625130
[TBL] [Abstract][Full Text] [Related]
7. French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time.
Roussi J; Drouet L; Samama M; Sié P
Thromb Haemost; 1994 Nov; 72(5):698-704. PubMed ID: 7900077
[TBL] [Abstract][Full Text] [Related]
8. [Prothrombin time and its standardization].
Kagawa K
Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
[TBL] [Abstract][Full Text] [Related]
9. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
Ts'ao C; Swedlund J; Neofotistos D
Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
11. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
12. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
[TBL] [Abstract][Full Text] [Related]
13. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
14. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
Kolde HJ
Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
[No Abstract] [Full Text] [Related]
15. [Evaluation of the quality of prothrombin time technique in the Basque Country].
Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
[TBL] [Abstract][Full Text] [Related]
16. [Obtaining a reference pattern of rabbit brain thromboplastin].
Martínez Placencia BM; Lanzetti Theiler MC; Córdova Caballero MS
Rev Invest Clin; 1989; 41(3):247-52. PubMed ID: 2813999
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
[TBL] [Abstract][Full Text] [Related]
18. Prothrombin time sensitivity and specificity to mild clotting factor deficiencies of the extrinsic pathway: evaluation of eight commercial thromboplastins.
Massignon D; Moulsma M; Bondon P; Debize G; Abidi H; Buttin T; Bon C; Pillonchery G; Coeur P
Thromb Haemost; 1996 Apr; 75(4):590-4. PubMed ID: 8743184
[TBL] [Abstract][Full Text] [Related]
19. [Quality control of ISI/INR system in oral anticoagulant therapy].
Kazama M
Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
[TBL] [Abstract][Full Text] [Related]
20. Multi-center study of replacement of the international reference preparation for thromboplastin, rabbit, plain.
van den Besselaar AM
Thromb Haemost; 1993 Nov; 70(5):794-9. PubMed ID: 8128437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
